Skip to main content
. Author manuscript; available in PMC: 2014 Mar 28.
Published in final edited form as: J Cardiovasc Pharmacol Ther. 2012 Nov 19;18(2):152–161. doi: 10.1177/1074248412458975

Figure 3. Cromolyn sodium reduces fibrosis by postmortem morphometry, 28 days after EAM induction.

Figure 3

Representative sections of the heart treated with cromolyn sodium (a) or saline (b) in Masson Trichrome staining. Morphometry shows that cromolyn treatment reduces proportion of fibrosis (c).